Werewolf Therapeutics (HOWL) Return on Sales [ROS] (2022 - 2026)
Werewolf Therapeutics (HOWL) posted Return on Sales [ROS] of 34.09% for Q2 2026, up 486734.09 percentage points from -486700.00% a year earlier.
Powered by 
Analysis
Werewolf Therapeutics (HOWL) Return on Sales [ROS] (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Werewolf Therapeutics was -148.84%, up 486551.16 percentage points year-over-year; for FY2024, it was -3873.37%, down 3670.27 percentage points from FY2023.
- In prior years, Werewolf Therapeutics' Return on Sales [ROS] was -203.09% in FY2023 (+138.69 pp) and -341.78% in FY2022.
- The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] in data going back to Q2 2022.
- On a year-over-year basis, Return on Sales [ROS] increased in 1 of the last six quarters, with an average year-over-year change of -102405.66 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2026, with a gain of 486734.09 percentage points; the weakest was Q2 2025, with a drop of 485041.21 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 28.37% |
| 10 | Werewolf Therapeutics | 48.84 Mn | -142.42 Mn | - | 34.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.09% |
| Sep 30, 2025 | -477,380.00% |
| Jun 30, 2025 | -486,700.00% |
| Mar 31, 2025 | -6,426.86% |
| Dec 31, 2024 | -135,653.33% |
| Sep 30, 2024 | -1,955.35% |
| Jun 30, 2024 | -1,658.79% |
| Mar 31, 2024 | -2,312.94% |
| Dec 31, 2023 | -863.56% |
| Sep 30, 2023 | -156.88% |
| Jun 30, 2023 | -75.08% |
| Mar 31, 2023 | -273.81% |
| Dec 31, 2022 | -180.96% |
| Sep 30, 2022 | -252.29% |
| Jun 30, 2022 | -360.95% |
API Access
Werewolf Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HOWL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "HOWL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HOWL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();